| Net Cash Provided by (Used in) Operating Activities |
$242,105,000 |
USD |
142% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$783,596,000 |
USD |
-750% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$172,552,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$368,799,000 |
USD |
-61% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$721,376,000 |
USD |
-13% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$204,576,000 |
USD |
23% |
Q4 2025 |
FY 2025 |
| Depreciation |
$190,219,000 |
USD |
7.1% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$255,756,000 |
USD |
24% |
Q4 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$14,093,000 |
USD |
-225% |
Q1 2025 |
Q1 2025 |
| Unrecognized Tax Benefits |
$531,000 |
USD |
|
Q4 2025 |
FY 2025 |
| Amortization of Intangible Assets |
$699,000 |
USD |
-9.3% |
Q1 2025 |
Q1 2025 |
| Depreciation, Depletion and Amortization |
$196,365,000 |
USD |
7.5% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$31,000,000 |
USD |
40% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$662,084,000 |
USD |
-6.2% |
Q4 2025 |
FY 2025 |